MY
Noveris Health Sciences Inc.
MYCOF · OTC
$0.73 +0.00% (+$0.00)
Market Cap $60.0M
P/E Ratio 36.70x
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
6 /100
Expensive EV/EBITDA 27.69x
P/E 36.70x
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
79 /100
Excellent Asset turnover 0.00x
ROIC 49.67%
ROA 165.32%
Debt
79 /100
Low Net debt/EBITDA -0.20x
Current ratio 0.31x
Int. coverage 46.96x
Stability
50 /100
Moderate Beta -5.44x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre MYCOF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Jason Birmingham
Employees
3
Headquarters
Vancouver
Evenimente viitoare
17 NOV.
Earnings
Upcoming earnings report